Technique enables development of viable diagnostic tests and instruments in fight against cancer
Cancer is the second leading cause of death in the U.S., making early, reliable diagnosis and treatment a priority for researchers. Genomic biomarkers offer great potential for diagnostics and new forms of treatment, such as immunotherapy. Miniaturized lab-on-chip approaches are prime candidates for developing viable diagnostic tests and instruments because they are small, need only limited test volumes, and can be cost-effective.
A team of scientists and engineers from the University of California, Santa Cruz and Brigham Young University have developed just such an approach capable of processing biomolecular samples from blood. Their method can analyze and identify multiple targets on a silicon-based molecular detection platform and is described this week in Biomicrofluidics, from AIP Publishing.
Laboratory–on-a-chip describes the miniaturization of laboratory functions such as blood testing on a chip. Instead of transferring relatively large (micro- to milliliters) samples between test tubes or using bulky analytical equipment, samples and reagents are handled on chip-scale devices with fluidic microchannels. This requires much smaller test volumes, and multiple functions can be integrated on a single device, improving speed, reliability and portability of these lab processes.
“Our approach uses optofluidic chips where both fluid processing and optical sensing are done on a chip, allowing for further miniaturization and performance enhancements of the chip system,” said Holger Schmidt, a Narinder Kapany professor of electrical engineering at the University of California, Santa Cruz.
The entire process of testing was a challenge for the team, led by Schmidt and Aaron Hawkins, a physics professor at Brigham Young University. Each of the chips had to be developed and tested for multiple functions, from filtering of blood cells without clogging the filter to reliably analyzing optical data to create the right excitation patterns on the silicon chip. However, the process worked as envisioned, and the team was pleasantly surprised to see just how powerful the multi-spot optical excitation method actually was.
The next step to realizing the potential of this research is to move toward real clinical samples and to detect individual DNA biomarkers.
“We have shown single nucleic acid analysis in the context of on-chip Ebola detection and would like to transfer that to this application,” said Schmidt.
Other goals for the team include increasing the speed of the analysis process, and integrating more optical elements on the chip. They also want to expand their capabilities to analyzing protein biomarkers in addition to nucleic acids and whole virus particles already demonstrated.
This research is expected to have a wide range of applications because the underlying principle of this kind of on-chip optical analysis and manipulation is very general.
“In the near term, we hope to build new diagnostic instruments for molecular diagnostics with applications in oncology and infectious disease detection, both viruses and (drug-resistant) bacteria,” Schmidt said. “In addition, these chips could be very useful for fundamental research in molecular biology and other life sciences since they can provide analysis of single nano- and microparticles without the need for expensive equipment. And they require a relatively low amount of experimental skills.”
Receive an email update when we add a new LAB-ON-A-CHIP article.
The Latest on: Lab-on-a-chip
via Google News
The Latest on: Lab-on-a-chip
- Japanese healthcare startup Bisu raises $3.2M seed round to launch its lab-on-a-chip producton October 6, 2021 at 6:00 pm
The adoption of telehealth services has boomed in the pandemic — with usage up 38-fold since January 2020, according to a report by McKinsey. While a lot of the attention has been on companies that ...
- Could BYU-developed lab-on-a-chip devices help save lives?on October 3, 2021 at 2:46 pm
An interdisciplinary team of researchers at BYU has developed a new 3D printing technique to create the smallest ever, high resolution microfluidic lab-on-a-chip devices.
- PCR Technologies Market worth $9.8 billion by 2025: Development of compact, portable, and lab-on-chip PCR deviceson September 30, 2021 at 6:10 pm
PCR technologies market is dominated by Thermo Fisher Scientific, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V.
- Intel Rolls Out New Loihi 2 Neuromorphic Chip: Built on Early Intel 4 Processon September 30, 2021 at 8:00 am
We’ve been keeping light tabs on Intel’s Neuromorphic efforts ever since it launched its first dedicated 14nm silicon for Neuromorphic Computing, called Loihi, back in early 2018. In an interview with ...
- BYU researchers make micro lab-on-a-chip breakthroughon September 30, 2021 at 7:58 am
Academic jargon can often confuse the average person about the topic at hand, but make no mistake on this, researchers at Brigham Young University have made a monumental leap — and people are talking ...
- Lab On A Chip Market May Observe A Giant Move | Key Players – BD, Agilent Technologies, Danaher.on September 30, 2021 at 7:36 am
Don’t Miss out the opportunity. New York, United States : Latest report published by Decisive Markets Insights on Lab On A Chip market has only 20 licensed copies left with us. We would like you to ...
- Lab-on-a-chip and Microarrays (Biochip) Market Size, Analysis, Competitive Strategies and Forecasts 2027on September 29, 2021 at 10:19 am
Market Study Report has added a detailed report on Lab-on-a-chip and Microarrays (Biochip) Market which has been categorized by market size, growth indicators and encompasses detailed market analysis ...
- Lab-on-a-Chip devices smaller than ever thanks to new 3D printing techniques from BYUon September 28, 2021 at 5:00 am
Researchers at Brigham Young University have demonstrated the ability to create microfluidic lab-on-a-chip devices with channels and valves smaller than ever before. Using a new 3D printing technique, ...
- Archer Materials well-funded to advance development of 12CQ quantum computing and ‘lab-on-a-chip’ biochip technologieson September 23, 2021 at 11:00 pm
Archer Materials Ltd (ASX:AXE, OTC:ARRXF) made considerable progress during the financial year ended June 30, 2021, and is well-funded to drive the ongoing development of its 12 CQ quantum computing ...
via Bing News